World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
117
Citations
54210
World Ranking
4192
National Ranking
410

Overview

Philip J. Johnson is affiliated with the University of Liverpool in the United Kingdom and has an extensive publication record focused primarily on medicine, with a significant emphasis on hepatology. Their research spans various subfields including hepatology, epidemiology, cancer research, oncology, and surgery.

Johnson's main topics of work include:

  • Liver Disease Diagnosis and Treatment
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Hepatitis C Virus Research
  • Liver Disease and Transplantation
  • Cancer, Lipids, and Metabolism
  • Hepatitis B Virus Studies
  • Pancreatic and Hepatic Oncology Research

Their frequent coauthors are:

  • Hidenori Toyoda
  • Sarah Berhane
  • Hamish Innes
  • Takashi Kumada
  • Alessandro Cucchetti

Johnson has published multiple papers in prominent venues. The frequent publication venues include:

  • Journal of Hepatology
  • British Journal of Cancer
  • JHEP Reports
  • Liver Cancer
  • Clinical Gastroenterology and Hepatology

Some of the recent papers featuring Philip J. Johnson as an author include:

  • Circulating biomarkers in the diagnosis and management of hepatocellular carcinoma, 2022, Nature Reviews Gastroenterology & Hepatology
  • aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis, 2020, Journal of Hepatology
  • The ALBI score: From liver function in patients with HCC to a general measure of liver function, 2022, JHEP Reports
  • Final Results of TACTICS: A Randomized, Prospective Trial Comparing Transarterial Chemoembolization Plus Sorafenib to Transarterial Chemoembolization Alone in Patients with Unresectable Hepatocellular Carcinoma, 2022, Liver Cancer
  • Locoregional therapies in patients with intrahepatic cholangiocarcinoma: A systematic review and pooled analysis, 2021, Cancer Treatment Reviews

The scientist's work concentrates especially on liver diseases, including hepatocellular carcinoma, and the development and evaluation of diagnostic biomarkers and treatment approaches. They have conducted research across epidemiological and clinical domains focusing on liver disease prognosis and therapy.

Best Publications

  • Quantitative Analysis of Fetal DNA in Maternal Plasma and Serum: Implications for Noninvasive Prenatal Diagnosis

    Y. M. Dennis Lo;Mark S.C. Tein;Tze K. Lau;Christopher J. Haines

  • Assessment of Liver Function in Patients With Hepatocellular Carcinoma: A New Evidence-Based Approach—The ALBI Grade

    Philip J. Johnson;Sarah Berhane;Chiaki Kagebayashi;Shinji Satomura

  • Meeting report: International autoimmune hepatitis group

    P. J. Johnson;Ian G. McFarlane

  • Efavirenz plus Zidovudine and Lamivudine, Efavirenz plus Indinavir, and Indinavir plus Zidovudine and Lamivudine in the Treatment of HIV-1 Infection in Adults

    Schlomo Staszewski;Javier Morales-Ramirez;Karen T. Tashima;Anita Rachlis

  • Global patterns of hepatocellular carcinoma management from diagnosis to death: The BRIDGE Study

    Joong Won Park;Minshan Chen;Massimo Colombo;Lewis Rowland Roberts

  • Quantitative Analysis of Cell-free Epstein-Barr Virus DNA in Plasma of Patients with Nasopharyngeal Carcinoma

    Y. M.Dennis Lo;Lisa Y.S. Chan;Kwok Wai Lo;Sing Fai Leung

  • Frequency of hepatitis B virus reactivation in cancer patients undergoing cytotoxic chemotherapy: a prospective study of 626 patients with identification of risk factors

    Winnie Yeo;Paul K.S. Chan;Sheng Zhong;Wing M. Ho

  • Brivanib Versus Sorafenib As First-Line Therapy in Patients With Unresectable, Advanced Hepatocellular Carcinoma: Results From the Randomized Phase III BRISK-FL Study

    Philip J. Johnson;Shukui Qin;Joong Won Park;Ronnie T.P. Poon

  • A randomized phase III study of doxorubicin versus cisplatin/interferon alpha-2b/doxorubicin/fluorouracil (PIAF) combination chemotherapy for unresectable hepatocellular carcinoma.

    Winnie Yeo;Tony S. Mok;Benny Zee;Thomas W. T. Leung

  • Detection of Aberrant p16 Methylation in the Plasma and Serum of Liver Cancer Patients

    Ivy H.N. Wong;Y. M.Dennis Lo;Jun Zhang;Choong Tsek Liew

  • Overall Survival After Concurrent Cisplatin-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma

    Anthony Tak-cheung Chan;Sing-fai Leung;Roger K.C. Ngan;Peter M.L. Teo

  • Diagnosis, prevention and management of hepatitis B virus reactivation during anticancer therapy†

    Winnie Yeo;Philip J. Johnson

  • Concurrent Chemotherapy-Radiotherapy Compared With Radiotherapy Alone in Locoregionally Advanced Nasopharyngeal Carcinoma: Progression-Free Survival Analysis of a Phase III Randomized Trial

    A.T.C. Chan;P.M.L. Teo;R.K. Ngan;T.W. Leung

  • Hepatitis C virus antibodies in chronic active hepatitis: pathogenetic factor or false-positive result?

    I. G. McFarlane;H. M. Smith;P. J. Johnson;G. P. Bray

  • Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

    Masatoshi Kudo;Kazuomi Ueshima;Masafumi Ikeda;Takuji Torimura

  • Doxorubicin plus sorafenib vs doxorubicin alone in patients with advanced hepatocellular carcinoma: a randomized trial.

    Ghassan K. Abou-Alfa;Philip Johnson;Jennifer J. Knox;Marinela Capanu

  • Quantitative and Temporal Correlation between Circulating Cell-Free Epstein-Barr Virus DNA and Tumor Recurrence in Nasopharyngeal Carcinoma

    Y. M. D. Lo;L. Y. S. Chan;A. T. C. Chan;S.-F. Leung

  • Sorafenib in combination with transarterial chemoembolisation in patients with unresectable hepatocellular carcinoma (TACE 2): a randomised placebo-controlled, double-blind, phase 3 trial.

    Tim Meyer;Tim Meyer;Richard Fox;Yuk Ting Ma;Paul J Ross;Paul J Ross

  • The Role of Serum Alpha-Fetoprotein estimation in the Diagnosis and Management of Hepatocellular Carcinoma

    Philip J. Johnson

  • Plasma Epstein-Barr Virus DNA and Residual Disease After Radiotherapy for Undifferentiated Nasopharyngeal Carcinoma

    Anthony T C Chan;Y. M Dennis Lo;Benny Zee;Lisa Y S Chan

Frequent Co-Authors

Winnie Yeo
Winnie Yeo Chinese University of Hong Kong
Anthony T.C. Chan
Anthony T.C. Chan Chinese University of Hong Kong
Paul B.S. Lai
Paul B.S. Lai Chinese University of Hong Kong
Tony Mok
Tony Mok Chinese University of Hong Kong
Y.M. Dennis Lo
Y.M. Dennis Lo Chinese University of Hong Kong
Roger Williams
Roger Williams Foundation for Liver Research
Ka-Fai To
Ka-Fai To Chinese University of Hong Kong
Hidenori Toyoda
Hidenori Toyoda Ogaki Municipal Hospital
Stephen L. Chan
Stephen L. Chan Chinese University of Hong Kong
Benny Chung-ying Zee
Benny Chung-ying Zee Chinese University of Hong Kong

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students considering a career in medicine, there are diverse online degree options that can help shape your journey. Many are searching for ways to fast-track their healthcare education, and several accredited programs now offer this flexibility.

For those aiming at advanced nursing roles, the shortest dnp programs online allow you to earn a Doctor of Nursing Practice in less time. Budget-minded students may wish to explore a cheapest dnp program, which provides high-quality education with lower tuition costs.

If you’re interested in starting your healthcare career quickly, a 6 month lpn program online could offer the fastest route to practical nursing. For those drawn to mental health, the fastest pmhnp program enables registered nurses to specialize as psychiatric mental health nurse practitioners in less time than traditional paths.

Whether your goal is to advance into specialized practice or quickly enter the nursing workforce, these flexible online pathways offer practical solutions for aspiring healthcare professionals.

Best Scientists Citing Philip J. Johnson

Trending Scientists

Recently Published Articles